NCT01165866View on ClinicalTrials.gov

Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis

PHASE4CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Gastroenteritis
Interventions
DRUG

Treatment 1. Metoclopramide

metoclopramide 0.3mg/kg maximum dose 10mg will be added in the burette and mixed with normal saline to make up 50cc of medication for intravenous administration.

DRUG

Treatment 2 Ondansetron

Single dose of Ondansetron 0.15 mg/kg

Trial Locations (1)

Unknown

Pediatric Emergency Centre, Al-Saad, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY